World's Best Scientists 2026 revealed!
Huub Schellekens

Huub Schellekens

D-Index & Metrics

Biology and Biochemistry

D-Index
72
Citations
18612
World Ranking
6299
National Ranking
162

Huub Schellekens publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Huub Schellekens sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 259 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Huub Schellekens D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Huub Schellekens sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 72 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Huub Schellekens is affiliated with Utrecht University in the Netherlands. Their research primarily focuses on the fields of Biochemistry, Genetics, and Molecular Biology, with significant contributions across related subfields including Computational Theory and Mathematics, Pharmacology, Molecular Biology, Endocrinology, and Food Science.

The main topics addressed in Schellekens's work include Computational Drug Discovery Methods, Enterobacteriaceae and Cronobacter Research, Probiotics and Fermented Foods, Animal Testing and Alternatives, Pharmacogenetics and Drug Metabolism, Biosimilars and Bioanalytical Methods, as well as Pharmaceutical Studies and Practices.

Schellekens has coauthored several papers with frequent collaborators such as Guilherme S. Ferreira, Wouter Boon, Ellen H.M. Moors, Francesco Scaglione, and Paola Minghetti. These partnerships have contributed to multiple publications in well-known scientific venues.

The scientist's recent publications include:

  • "Comparison of drug efficacy in two animal models of type 2 diabetes: A systematic review and meta-analysis," 2020, European Journal of Pharmacology
  • "Pathways in the Drug Development for Alzheimer's Disease (1906-2016): A Bibliometric Study," 2020, Journal of Scientometric Research
  • "Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs," 2023, Translational Psychiatry
  • "Nature of the Interaction of Alpha-D-Mannose and Escherichia coli Bacteria, and Implications for its Regulatory Classification. A Delphi Panel European Consensus Based on Chemistry and Legal Evidence," 2023, Therapeutic Innovation & Regulatory Science
  • "The devolution of biosimilars regulations," 2024, Nature Biotechnology

Publication venues where Schellekens has contributed multiple works include Preprints.org, Journal of Scientometric Research, Translational Psychiatry, European Journal of Pharmacology, and Therapeutic Innovation & Regulatory Science.

Best Publications

  • γ Interferon, CD8 + T cells and antibodies required for immunity to malaria sporozoites

    Louis Schofield;Jaime Villaquiran;Arturo Ferreira;Huub Schellekens

  • THE HEPATITIS DELTA (DELTA) VIRUS POSSESSES A CIRCULAR RNA

    A. Kos;R. Dijkema;A. C. Arnberg;P. H. van der Meide

  • Structure-immunogenicity relationships of therapeutic proteins.

    Suzanne Hermeling;Daan J. A. Crommelin;Huub Schellekens;Wim Jiskoot

  • Immunogenicity of therapeutic proteins: clinical implications and future prospects.

    Huub Schellekens

  • Bioequivalence and the immunogenicity of biopharmaceuticals

    Huub Schellekens

  • Factors influencing the immunogenicity of therapeutic proteins

    Huub Schellekens

  • The Immunogenicity of Polyethylene Glycol: Facts and Fiction

    Huub Schellekens;Wim E. Hennink;Vera Brinks

  • Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon

    A Ferreira;L Schofield;V Enea;H Schellekens

  • Safety-Related Regulatory Actions for Biologicals Approved in the United States and the European Union

    Thijs J. Giezen;Aukje K. Mantel-Teeuwisse;Sabine M. J. M. Straus;Huub Schellekens

  • 9-(2-Phosphonylmethoxyethyl)adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus infection in rhesus monkeys.

    Balzarini J;Naesens L;Slachmuylders J;Niphuis H

  • Cloning and expression of the chromosomal immune interferon gene of the rat.

    R. Dijkema;P.H. van der Meide;P.H. Pouwels;M. Caspers

  • Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics.

    Johan J F Verhoef;John F Carpenter;Thomas J Anchordoquy;Huub Schellekens

  • The Purification and Characterization of Rat Gamma Interferon by Use of Two Monoclonal Antibodies

    P H van der Meide;M Dubbeld;K Vijverberg;T Kos

  • Immunological mechanism underlying the immune response to recombinant human protein therapeutics.

    Melody Sauerborn;Vera Brinks;Wim Jiskoot;Huub Schellekens

  • Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

    Chris H. Polman;Antonio Bertolotto;Florian Deisenhammer;Gavin Giovannoni

  • Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation.

    Suzanne Hermeling;Huub Schellekens;Coen Maas;Martijn F.B.G. Gebbink

  • Biosimilar therapeutics--what do we need to consider?

    Huub Schellekens

  • γ‐interferon treatment inhibits collagen deposition in murine schistosomiasis

    M. J. Czaja;F. R. Weiner;S. Takahashi;M. A. Giambrone

  • Immunogenicity of biopharmaceuticals

    Michele Kessler;David Goldsmith;Huub Schellekens

  • The immunogenicity of biopharmaceuticals.

    Huub Schellekens

Frequent Co-Authors

Wim Jiskoot
Wim Jiskoot Leiden University
Hubert G. M. Leufkens
Hubert G. M. Leufkens Utrecht University
Daan J.A. Crommelin
Daan J.A. Crommelin Utrecht University
Marko P. Hekkert
Marko P. Hekkert Utrecht University
Marc A. Koopmanschap
Marc A. Koopmanschap Erasmus University Rotterdam
Gavin Giovannoni
Gavin Giovannoni Queen Mary University of London
Hans-Peter Hartung
Hans-Peter Hartung Heinrich Heine University Düsseldorf
Wim E. Hennink
Wim E. Hennink Utrecht University
Bernhard Hemmer
Bernhard Hemmer Technical University of Munich
Geert Maertens
Geert Maertens Biocartis (Belgium)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA can open doors to a variety of related healthcare and science careers. With the rise of digital learning, many students are now pursuing degrees and certifications online, combining flexibility with quality education.

For those interested in diagnostic imaging, an online ultrasound tech school can lead to roles in medical sonography. Similarly, rad tech online programs offer pathways into radiologic technology, a fast-growing healthcare field.

Nutrition science enthusiasts may consider one of the top dietetics programs in the us for advanced studies. If you're interested in clinical support roles, a variety of medical assistant programs online michigan options provide the skills needed to start a rewarding healthcare career.

Exploring these related online pathways can complement your biology or biochemistry background and expand your professional opportunities in the thriving U.S. healthcare sector.

Best Scientists Citing Huub Schellekens

Trending Scientists